Company

MBrace Therapeutics, Inc.

MBrace Therapeutics develops antibody-drug conjugates for cancer treatment.

About

MBrace Therapeutics is a clinical-stage pharmaceutical company developing antibody-drug conjugates for cancer targets. Founded in 2020, it is based in San Diego, US. In November 2023, it raised USD 85 million in Series B funding led by TPG, with participation from Avidity Partners and Cowen Healthcare Investments.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in